Health technology assessment of the remote monitoring of patients with implanted cardiac devices by KCE in Belgium

07

Dec 2021

On November 9, 2021, the Belgian Health Care Knowledge Center (KCE) published the health technology assessment report "Remote monitoring of patients with cardiovascular implantable electronic devices (CIED)". The aim of the report was to summarize the existing clinical and economic evidence on the remote monitoring of patients with CIEDs, i.e., implantable cardioverter-defibrillators (ICDs), pacemakers (PMs), cardiac resynchronization therapy devices with only pacemaker function (CRT-P), cardiac resynchronization therapy devices with a defibrillator function (CRT-D), and implantable loop recorders (ILRs), and to investigate reimbursement practices in other countries in order to provide recommendations for potential reimbursement of these technologies.

Analysis of efficacy and safety of remote monitoring showed the following advantages for the patients, i.e., a 'protocol-based' reduction of in-clinic visits, earlier detection of events, reduced risk of inappropriate shocks, and a lower burden of atrial arrhythmias, but, overall, there was no significant effect of remote monitoring on their health-related quality of life, hospitalizations, or mortality.

Cost-effectiveness analysis indicates that remote cardiac monitoring of ICDs and PMs is cost-effective compared to monitoring exclusively based on in-clinic visits. No relevant studies were identified for ILRs. The cost-effectiveness of remote monitoring for Belgium could not be investigated due to the lack of Belgian-specific data.

Except for efficacy, safety, and cost-effectiveness, reimbursement and organizational aspects for remote monitoring in France, the Netherlands, and Germany, and potential financing models for Belgium, as well as a budget impact, were analyzed.

The full details in English can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

27

Jan 2023

On January 09, 2023, the National Institute for Health and Disability Insurance (INAMI-RIZIV) published 2023 tariffs for the “low variability care” (APR-DRG) system. APR-DRG logic for 2023 is not published as of January 27, so no information about its changes or new DRGs is available.

Read more

25

Jan 2023

On December 31, 2022, the Decree defining the reimbursement of medical telemonitoring activities via the new framework was published in the Official Journal of the French Republic. The Decree determines the methods of evaluation of digital solutions, registration for reimbursement, modification of the registration conditions, removal and invoicing of medical telemonitoring activities, as well as the conditions for setting the reimbursement packages.

Read more

24

Jan 2023

In December 2022, NHS England launched a consultation on the preliminary 2023/25 NHS Payment Scheme, which is set for two years and will replace the National Tariff Payment System from April 2023. Two new cardiovascular categories (antibacterial envelope, mitral valve repair and replacement devices) are proposed for inclusion in the 2023/24 High Cost Device List (will be updated and reissued for 2024/25). The deadline for comments submission is January 27, 2023.

Read more

20

Jan 2023

In December 2022, the National Institute for Health and Care Research (NIHR) in England released six MedTech-related reports in its Health Technology Assessment (HTA) Journal, which concerned laser therapy in diabetic macular oedema, EarlyCDT Lung blood test, video-assisted thoracoscopic or open lobectomy, urethral slings for stress urinary incontinence, placental growth factor (PlGF) and sFlt-1 tests, and photobiomodulation in the management of oral mucositis. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.

Read more

12

Jan 2023

In December 2022, the National Institute for Health and Care Excellence (NICE) published one new Medical Technologies Guidance (Memokath 051 Ureter stent for ureteric obstruction) and one MedTech Innovation Briefing (PromarkerD). Also, two new clinical guidelines were published, and one was updated.

Read more